Uluru Inc. (fka ULUR)

[mlkrborn]

ULU 0.37 with euro zone partnership:
ULURU announces Altrazeal agreement for the European market (ULU) 0.32 : Co announced that it has signed a binding letter of intent with Melmed Holdings AG, a company based in Switzerland, to license Altrazeal for the European Union. Under the terms of the agreement ULURU will license the European Union rights to a subsidiary of Melmed Holdings AG specifically formed to market Altrazeal in the European Union. In exchange for the license ULURU will receive a licensing payment and a 25% interest in the Altrazeal marketing subsidiary that have a combined value of ~$2.5 mln. In addition, ULURU will supply Altrazeal at a price equal to 30% of the European sales price and will receive a royalty on sales within the territory.